Johnson Pharmaceuticals 2026 Interim Performance: Double-Digit Growth in Revenue, Profit, and R&D Investment as Multiple Key Pipeline Entries Enter Registration Phase
August 26, 2026 — 22:25 CST
This Data Is Locked!
This area is available only to Subscribers.
Johnson Pharmaceuticals announced its 2026 interim performance with significant growth in revenue, profit, and research and development (R&D) investment. In the first half of 2026,... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals
